CNS Pharmaceuticals, Inc. 8-K

What Happened CNS Pharmaceuticals, Inc. (CNSP) filed a Form 8-K on March 11, 2026 disclosing under Item 7.01 (Regulation FD Disclosure) that it posted an investor presentation on its website. The presentation was included as Exhibit 99.1 to the filing.

Key Details

• Filing date: March 11, 2026 (Form 8-K).
• Disclosure type: Regulation FD (Item 7.01) — public release of investor presentation.
• Exhibit filed: 99.1 (Presentation dated March 2026). The filing also included the interactive cover page data (Exhibit 104).

Why It Matters Posting an investor presentation under Regulation FD ensures the company is making material information available to all investors at the same time. For retail investors, this presentation may provide updated business, clinical, or strategic information directly from CNSP management; investors should review the presentation on the company website or in Exhibit 99.1 of the 8-K for specifics.